Trial · NCT04167813
Trial of Ondansetron as a Parkinson's HAllucinations Treatment
NCT04167813, Phase 2, Unknown, University College, London
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Trial of Ondansetron as a Parkinson's HAllucinations Treatment. Trials, record NCT04167813. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04167813
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Trial of Ondansetron as a Parkinson's HAllucinations Treatment
- NCT number
- NCT04167813
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 168 participants, actual
- Lead sponsor
- University College, London
- Conditions
- Parkinson's Hallucinations, Dementia With Lewy Bodies
- Interventions
- Ondansetron 8mg or matched placebo tablets
- First posted
- 2019-11-19
- Last updated
- 2024-03-27
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Hallucinations | 12 weeks | Scale for Assessment of Positive Symptoms-Hallucinations (0-35 points, higher scores indicate greater severity of hallucinations |
| Secondary | Delusions | 2, 4, 6, 12, 18, 24 weeks | Scale for Assessment of Positive Symptoms-Delusions (0-65 points, higher scores indicate greater symptom severity |
| Secondary | Safety and tolerability | 2, 4, 6, 12, 18, 24 weeks | Number of Participants With Treatment-Related Adverse Events |
| Secondary | Health related quality of life | 6, 12, 18, 24 weeks | EQ-5D-5L |
| Secondary | Cost effectiveness | 2, 4, 6, 12, 18, 24 weeks | Health and social service utilisation |
| Secondary | Pharmacokinetics, plasma concentrations of the study drug | 6, 12 weeks | Measured using a validated HPLC/MS assay |
| Secondary | Hallucinations | 2, 4, 6, 18, 24 weeks | Scale for Assessment of Positive Symptoms-Hallucinations (0-35 points, higher scores indicate greater severity of hallucinations |
| Secondary | Global illness severity | 2, 4, 6, 12, 18, 24 weeks | Clinical Global Impression of Severity Scale (1-7, higher scores indicate greater severity) |
| Secondary | Non-motor symptoms | 2,4,6,12,18,24 weeks | Non-motor symptoms scale (0-120, higher scores indicate greater severity |
| Secondary | Cognition | 12 weeks | Standardised Mini-Mental State Examination (0-30, higher scores indicate better performance) |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04167813
GET https://conductscience.org/api/trials/v1/NCT04167813/registered